CClinicalTrials.gg
RecruitingNCT06908447CoVaUpdated Apr 21, 2026

Cold Water and Decision-Making

An interventional study of Cold-water immersion and Warm-water immersion (Control) in Behavior, Stress and Quality of Life, sponsored by German Institute of Human Nutrition. Recruiting at 1 site in Germany. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by German Institute of Human Nutrition · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The behavioral within-subject cross-over design study "CoVa" aims to investigate the effect of a short-term full-body cold-water immersion vs. warm-water immersion control on value-based choice, psychological well-being, and peripheral physiology.

Read the detailed description

This randomized within-subject cross-over design behavioral study in cognitive neuroscience will employ an acute peripheral physiological intervention, i.e., a 10-minute full-body cold-water (10-16°C) immersion vs. a control condition (10 min @ 30- 36°C water) on two visits separated by approx. 30 days.

Forty eligible female and male participants will be subject to a head-out full-body cold-water immersion or a warm-water condition (control) on two visits. Participants will perform resting-state and task-based non-invasive electrophysiological recordings of the heart, pulse, respiration, skin conductance, and pupil, will undergo thermographic imaging, pre- and post-immersion blood sampling (4 time points), engage in two computer-based decision-making tasks (reinforcement learning task, risk decision-making task), a brief food choice task, and receive a battery of psychometric questionnaires. The visits are separated by approximately 30 days and do not differ in their timeline except for the primary intervention, i.e., cold vs warm-water immersion, and the medical screening on visit 1.

02

Conditions studied

  • Behavior
  • Stress
  • Quality of Life
  • Psychological Wellbeing

Browse trials for

Keywords

  • Decision-Making
  • Psychology
  • Stress
  • Cold-Exposure
  • Cold-Water Immersion
03

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18-40 years of age
  • Consent to participate
  • Fluency in German
  • Physically and mentally healthy
  • BMI 18-30 kg/m2
  • Normal day-night rhythm

Exclusion criteria

Exclusion Criteria:

  • Raynaud syndrome
  • Cold urticaria
  • High resting heart rate (>160 beats per minute)
  • Acute infection
  • Diagnosed current or former illnesses of

    • Brain and mind
    • Heart and blood circulation
    • Gastrointestinal system
    • Endocrine system
    • Other serious past or present medical conditions
  • Wearing of medical devices (e.g., pacemaker)
  • Fear of blood, needles, or phlebotomy
  • Allergies to plasters, gels, and other medical equipment
  • Allergies to commercially available liquid meals (e.g., shakes, yfood Labs GmbH)
  • Recurrent intake of medication which affect metabolism
  • Regular nicotine consumption (e.g., vaping, cigarettes)
  • Excessive alcohol consumption (>14 servings/week)
  • Recent illegal drug consumption (within 2 weeks prior)
  • Strong mental or physical stress
  • Excessive exercise (>2 h high-intensity exercise/day)
  • Pregnancy or breastfeeding
  • Inability to wear skin-exposing swimwear, e.g., for religious reasons
  • Affinity for winter swimming, cryotherapy, breathwork (>3 times/year)
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Cold-water immersion

    Behavioral: Cold-water immersion

  • Experimental
    Warm-water immersion (Control)

    Behavioral: Warm-water immersion (Control)

Interventions

  • BehavioralCold-water immersion

    Single 10-minute acute full-body head-out single arm-out cold-water immersion at 10-16°C on the experimental day

  • BehavioralWarm-water immersion (Control)

    Single 10-minute acute full-body head-out single arm-out cold-water immersion at 30-36°C on the experimental day

05

What researchers measure

Primary outcomes

  1. Risk propensity

    Risk propensity, i.e., the ratio between risky and non-risky choices for each monetary value as measured in the risk decision-making task in the cold-water vs warm-water condition as described in Liu et al. (2021)

    Time frame: On day 1 and after 30 days

  2. Behavioral range adaptation

    Participants will perform a computer-based reinforcement learning task described in Gueguen et al. (2024) to assess reward sensitivity in different monetary contexts. Behavioral range adaptation, which reflects value range-dependent, relative reward valuation, may be altered if reward processing itself is changed through a potent shift in the physiological state. To test whether reward processing is altered after cold vs warm water exposure, the extent to which range adaptation and reference-point centering occurs will be quantified using computational modeling methods.

    Time frame: On day 1 and after 30 days

  3. Food choice

    Participants will be provided an ad libitum restaurant-like breakfast meal during which they can order various food items (e.g., bread, yogurts, cookies) in the desired amount. The ingested food type, nutritional value, and amount will be quantified to assess food preference after cold vs warm water exposure by linking the consumed food with a standardized food database (German Nutrient Database, Bundeslebensmittelschlüssel).

    Time frame: On day 1 and after 30 days

  4. Heart-rate variability

    Task-based and resting-state heart-rate variability, measured with a three-point electrocardiogram (ECG)

    Time frame: On day 1 and after 30 days

  5. Heart rate

    Task-based and resting-state heart rate, measured with ECG

    Time frame: On day 1 and after 30 days

  6. Respiration rate

    Task-based and resting-state respiration rate, measured via a respiration belt

    Time frame: On day 1 and after 30 days

  7. Relative amplitude of the respiratory signal

    Task-based and resting-state relative respiratory amplitude, measured via a respiratory belt

    Time frame: On day 1 and after 30 days

  8. Event-related skin conductance responses

    Phasic electrodermal activity, measured via electrodermal activity (EDA) electrodes

    Time frame: On day 1 and after 30 days

  9. Tonic skin conductance

    Tonic task-based and resting-state electrodermal activity, measured with EDA electrodes

    Time frame: On day 1 and after 30 days

  10. Pupil dilation

    Task-based and resting-state pupil dilation, measured via eye-tracking

    Time frame: On day 1 and after 30 days

  11. Skin temperature

    Thermographic imaging of the face, full-body, supraclavicular, and scapular area using a thermal camera pre-, during, and post-immersion

    Time frame: On day 1 and after 30 days

  12. Plasma concentration of large neutral amino acids

    Large neutral amino acid (LNAA) plasma concentration will be assessed via blood sampling at 4 time points (pre-immersion to 120 min post-immersion)

    Time frame: On day 1 and after 30 days

  13. Plasma concentration of catecholamines

    Catecholamines via blood sampling at 4 time points (pre-immersion to 120 min post-immersion)

    Time frame: On day 1 and after 30 days

  14. Plasma concentration of cortisol

    Cortisol via blood sampling at 4 time points (pre-immersion to 120 min post-immersion)

    Time frame: On day 1 and after 30 days

  15. Identification of epigenetic markers associated with acute cold exposure

    Epigenetic markers (micro-RNA) via blood sampling at 4 time points (pre-immersion to 120 min post-immersion)

    Time frame: On day 1 and after 30 days

  16. Perceived control

    Psychological changes in perceived control, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating high perceived control.

    Time frame: On day 1 and after 30 days

  17. Perceived freedom

    Psychological changes in perceived freedom, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating high perceived freedom.

    Time frame: On day 1 and after 30 days

  18. Perceived stress

    Psychological changes in perceived stress, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating high perceived stress.

    Time frame: On day 1 and after 30 days

  19. State of flow

    Psychological changes in perceived state of flow, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating a high state of flow.

    Time frame: On day 1 and after 30 days

  20. Self-efficacy

    Psychological changes in self-efficacy, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating high self-efficacy.

    Time frame: On day 1 and after 30 days

  21. Perceived pain

    Psychological changes in perceived pain, measured semi-continuously via self-reports throughout the experimental day. Measures range from 0% (not at all) to 100% (very much) with 100% indicating high perceived pain.

    Time frame: On day 1 and after 30 days

  22. Emotions

    Psychological changes in emotions and their bodily origins, measured via self-reports pre- and post-immersion. Measures will be drawn on a virtual body using an adapted version of the Nummenmaa et al. (2014) emBODY tool with red color indicating increased perception and blue indicating decreased perception.

    Time frame: On day 1 and after 30 days

  23. Positive affect and negative affect questionnaire

    Psychological changes in affect, measured semi-continuously via the Positive Affect Negative Affect (PANAS) questionnaire to be filled out pre- and post-immersion. Measures for each item range from 1 (not at all) to 5 (very much) with 5 indicating the highest feeling perceived at the moment.

    Time frame: On day 1 and after 30 days

Secondary outcomes

  1. Trait autonomy questionnaire

    Trait autonomy is assessed via the Basic Psychological Need Satisfaction and Frustration Scale (BPNSFS). Measures range from 1 (not at all true) to 5 (totally true) with 5 indicating the highest score.

    Time frame: On day 1 and after 30 days

  2. Emotion regulation questionnaire

    Emotion regulation, assessed via the Emotion Regulation Questionnaire (ERQ). Measures range from 1 (not at all true) to 7 (totally true) with 7 indicating the highest score.

    Time frame: On day 1 and after 30 days

  3. Causality orientation questionnaire

    Causality orientation, assessed via the General Causality Orientations Scale (GCOS). Measures range from 1 (very unlikely) to 6 (very likely) with 6 indicating the highest probability of responding as the item describes in the vignette scenario.

    Time frame: On day 1 and after 30 days

  4. Delay discounting questionnaire

    Delay discounting is assessed via the Delay Discounting Test by Kirby. Response options to each item are binary with one option corresponding to an immediate reward (e.g., 14 EUR today) and the second option corresponding to a higher but delayed reward (e.g., 19 EUR in 60 days).

    Time frame: On day 1 and after 30 days

  5. Interoceptive awareness questionnaire

    Interoceptive awareness, assessed via the Multidimensional Assessment of Interoceptive Awareness (MAIA) questionnaire. Measures range from 0 (never) to 5 (always) with 5 indicating the highest response.

    Time frame: On day 1 and after 30 days

  6. Generalized self-efficacy questionnaire

    Generalized self-efficacy, assessed via the Self-Efficacy Scale (SWE). Measures range from "not at all true", "hardly true", "moderately true" and "exactly true". A higher score, indicated by a preference for "exactly true", indicated more self-efficacy.

    Time frame: On day 1 and after 30 days

  7. Trait and state anxiety questionnaire

    Trait and state anxiety, assessed via the State-Trait Anxiety Inventory (STAI-S and STAI-T). State anxiety is assessed on a scale from 1 (not at all) to 8 (very much) with a higher score indicating high state anxiety. Trait anxiety is assessed on a scale from 0 (almost never) to 3 (almost always) with a higher score indicating high trait anxiety.

    Time frame: On day 1 and after 30 days

  8. Well-being questionnaire

    Psychological well-being is assessed via the short version of the Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS). Responses range from "never" to "always" on a 5-point scale with a high score indicating higher mental well-being in the past two weeks.

    Time frame: On day 1 and after 30 days

06

Study locations

1 of 1 sites recruiting
  • German Institute of Human Nutrition Potsdam-Rehbruecke
    Nuthetal, Germany
    Recruiting
07

References and documents

Related links

08

Registry details

Key details

Study ID
NCT06908447
Lead sponsor
German Institute of Human Nutrition
Responsible party
Prof. Dr. Soyoung Q Park (Prof. Dr., German Institute of Human Nutrition) — Principal investigator
First posted
Apr 3, 2025
Start date
Aug 28, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Apr 21, 2026

Study contacts

Trust Centre of the Human Study Centre Recruitment Officer
Contact
CoVa-Studie@dife.de
+4933200 882753
Mine Schmidt
Contact
mine.schmidt@dife.de
+4933200 882518
Soyoung Q Park, Prof. Dr.
principal investigator · German Institute of Human Nutrition Potsdam-Rehbruecke

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion